Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

2(33.3%)

N/A

2(33.3%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 4(2)

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02322060Completed

In Vitro Activation of Dormant Follicles for Patients with Primary Ovarian Insufficiency

Role: collaborator

NCT06560710Completed

Clinical Characteristics and Surgical Outcomes of Full-thickness Macular Hole Without Focal Vitreomacular Traction.

Role: lead

NCT02735707Phase 3Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Role: collaborator

NCT04395781Completed

Pediatric Acute and Critical Care COVID-19 Registry of Asia

Role: collaborator

NCT04131244Not ApplicableCompleted

In Vitro Follicle Activation in Patient With Premature Ovarian Failure Under 36 Years Old

Role: collaborator

NCT02144662Not ApplicableCompleted

Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion

Role: lead

NCT00190580Phase 4Completed

Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

Role: collaborator

NCT01343355Phase 2Unknown

Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)

Role: lead

NCT00407680Phase 4Unknown

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Role: collaborator

All 9 trials loaded